POSTMENOPAUSAL OSTEOPOROSIS
Clinical trials for POSTMENOPAUSAL OSTEOPOROSIS explained in plain language.
Never miss a new study
Get alerted when new POSTMENOPAUSAL OSTEOPOROSIS trials appear
Sign up with your email to follow new studies for POSTMENOPAUSAL OSTEOPOROSIS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Bone-Building drugs face off in osteoporosis trial
Disease control OngoingThis study looks at how well two FDA-approved medications work to strengthen bones in postmenopausal women who are at high risk for fractures. About 50 women will take one of the drugs for 12 months, and researchers will measure changes in hip bone density. The goal is to find ou…
Matched conditions: POSTMENOPAUSAL OSTEOPOROSIS
Phase: PHASE4 • Sponsor: Massachusetts General Hospital • Aim: Disease control
Last updated May 17, 2026 07:22 UTC
-
New bone drug shows promise for older women
Disease control OngoingThis study tests a new medicine called AGA2118 to see if it can improve bone density in postmenopausal women who have weak bones but no fractures. About 379 healthy women aged 55 to 80 with low bone mineral density will receive either the drug or a placebo for 12 months. The main…
Matched conditions: POSTMENOPAUSAL OSTEOPOROSIS
Phase: PHASE2 • Sponsor: Angitia Biopharmaceuticals • Aim: Disease control
Last updated May 14, 2026 12:06 UTC